Induction of ADAM12 by Twist1 promotes invadopodia formation and focal adhesion turnover to facilitate Twist1-induced tumor invasion and metastasis.
Introduction
During metastasis, carcinoma cells acquire the ability to invade surrounding tissues and intravasate through the endothelium to enter the systemic circulation. The basic helixloop-helix transcription factor Twist1 is a potent promoter of tumor metastasis and its expression is associated with poor outcome in many human cancers. Mechanistically, Twist1 can induce Epithelial-Mesenchymal Transition (EMT) to allow tumor cells to dissociate from each other and promote dissemination (Yang et al., 2004; Tsai et al., 2012) . Furthermore, Twist1 induces invadopodia formation and extracellular matrix (ECM) degradation to promote tumor invasion (Eckert et al., 2011) . Invadopodia are specialized actin-based membrane protrusions found in cancer cells that degrade ECM via localization of proteolytic activity (Chen, 1989; Tarone et al., 1985) . Their ability to mediate focal ECM degradation suggests a critical role for invadopodia in tumor invasion and metastasis. As actin-based structures, invadopodia contain a F-actin core and actin regulatory proteins, such as cortactin, WASp, and the Arp2/3 complex (Linder, 2007) . The SH3-domain-rich proteins Tks4 (Buschman et al., 2009 ) and Tks5 function as essential adaptor proteins in clustering structural and enzymatic components of invadopodia. The matrix degradation activity of invadopodia has been associated with a large number of proteases, including membrane type MMPs (MT1-MMP) (Linder, 2007) .
Invadopodia formation requires tyrosine phosphorylation of several invadopodia components including cortactin (Ayala et al., 2008) , Tks4 (Buschman et al., 2009) , and Tks5 likely by Src family kinases. Our previous study showed that Twist1 induces expression and activation of PDGFRα, which in turn activates Src kinase to promote invadopodia assembly (Eckert et al., 2011) . However, it is unclear whether Twist1 also engages additional downstream genes to promote the assembly and function of the complex invadopodial structure.
ADAM12 is a member of the disintegrin and metalloproteinase family united by the common feature of possessing both a metalloprotease and a disintegrin domain (Kveiborg et al., 2008) . ADAM12 is associated with disease stage in both breast and bladder cancer (Frohlich et al., 2006; Narita et al., 2012) . Interestingly, ADAM12 is induced during TGFβ-induced EMT (Ruff et al., 2015) . In addition, expression of ADAM12 has been reported in
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Induction of ADAM12 by Twist1 is required for Twist1-induced tumor metastasis.
Given the robust induction of invadopodia following Twist1 expression, we first sought to identify candidate genes downstream of Twist1 in regulating invadopodia-mediated ECM degradation. Using human breast cancer TCGA RNA-seq dataset (817 samples), we examined genes that were co-expressed with Twist1 and found that ADAM12, a protein previously shown to interact with Tks5 and localize at invadopdia was highly correlated with Twist1 expression in human breast cancers (Fig. 1A) . Furthermore, ADAM12 is ranked at 61th among total 16393 genes (99.6 percentile) in its association with Twist1 (Fig. 1B ). This correlation was further validated in four published large human breast tumor gene expression datasets summarizing 860 primary breast cancers (Pawitan et al., 2005; Sotiriou et al., 2006; Wang et al., 2005; Miller et al., 2005) . In each data set, we calculated the rank-based
Spearman correlation coefficient between Twist1 and all 22282 genes on the array, including ADAM12. Expression of Twist1 and ADAM12 were positively correlated with correlation coefficients ranging from 0.49 to 0.58 ( Fig. S1A-S1D ). ADAM12 was consistently among the top ranked genes associated with Twist1 (99.2 percentile in GSE2990, 99.1 percentile in GSE2034, 99.3 percentile in GSE3494, and 98.4 percentile in GSE1456) in all four breast cancer datasets ( Fig. S1E-S1H ).
To determine whether ADAM12 was in fact upregulated following Twist1 activation, we first utilized a Twist1-estrogen receptor (Twist1-ER) fusion protein construct that can be activated to enter the nucleus to drive Twist1-dependent transcription upon addition of 20nM 4-hydroxy tamoxifen (4-OHT) (Mani et al., 2008) . Upon Twist1-ER activation at time points from Day 0 to 14, a robust induction of ADAM12 expression was observed (Fig. 1C) .
Furthermore, in HMLE cells overexpressing Twist1, we also observed strong upregulation of ADAM12 protein; the two bands likely correspond to long and short isoforms of ADAM12 due to alternative splicing ( Fig. 1D ) . To determine whether endogenous ADAM12 expression is regulated by Twist1 in human breast cancer cells, we knocked down Twist1 in Hs578T cells by lentiviral-mediated shRNA delivery (Yang et al., 2004) .
Knocking down Twist1 also significantly reduced expression of ADAM12 (Fig. S2A ). We therefore concluded that Twist1 is both necessary and sufficient for induction of ADAM12 expression.
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Because our previous studies show that Twist1 plays a critical role in tumor invasion and metastasis (Yang et al., 2004 ) (Eckert et al., 2011) , we set out to investigate the effects of ADAM12 on Twist1-induced invasion and metastasis. We first virally transduced HMLETwist1 cells with two shRNAs against ADAM12 (shADAM12.1 and shADAM12.4). Both constructs were efficient at stably knocking down ADAM12 expression at the protein level in HMLE-Twist1 cells (Fig. 1D) . It is important to note that knockdown of ADAM12 did not affect cell proliferation, nor did it revert the EMT phenotype in HMLE-Twist1 cells ( Fig.   S2B-S2D ). HMLE-Twist1 cells expressing shADAM12 constructs still downregulated epithelial markers such as E-cadherin and upregulated mesenchymal markers such as neuronal-cadherin (N-cadherin) (Fig. 1D) . Importantly, knockdown of ADAM12 did not affect levels of MT1-MMP (Fig. 1D ). Therefore, ADAM12 is not required for the ability of Twist1 to induce EMT in 2D culture.
Next we tested whether ADAM12 was required for invasion in a 3D culture system by embedding HMLE-Twist1 cells expressing the control or shADAM12 constructs in a Matrigel-collagen culture system. After one week in 3D Matrigel-collagen culture, cells expressing the control knockdown had projected into the surrounding matrix; in contrast, HMLE-Twist1-shADAM12 cells remained largely rounded with few projections into the surrounding ECM (Fig. 1E) . Further quantification showed a significant decrease in 3D
invasiveness of HMLE-Twist1-shADAM12 cells (Fig. 1F) , suggesting a critical role of ADAM12 in promoting invasion in the 3D culture.
To determine whether ADAM12 promotes Twist1-induced metastatic dissemination in vivo, we first transformed the HMLE-Twist1 cells expressing shCtrl or shADAM12 constructs with oncogenic H-Ras and labeled the cells with GFP. Then we subcutaneously injected cells along with Matrigel into the flanks of nude mice. Approximately 40 days later, when tumors reached 1.5 cm in diameter, we sacrificed the mice and collected lung and primary tumor tissue for further analysis. Knocking down ADAM12 did not affect cell proliferation in culture (Fig. S2B ) or primary tumor growth in mice (Fig. 2D ). To examine local invasion, we stained tumor cells for Large T antigen as the HMLE cells were immortalized with SV40 Large T Antigen. HMLER tumors expressing a control shRNA presented poorly defined borders and single tumor cells often projected into the surrounding tissue (Fig. 2A) ; in contrast, the periphery of HMLER tumors expressing shADAM12
Journal of Cell Science • Advance article constructs remained largely encapsulated in a layer of connective tissue. When we examined the lungs for GFP-positive disseminated tumor cells, we observed significant decrease in disseminated cells in the HMLER-Twist1 tumors expressing the shADAM12 construct compared to control tumors ( Fig. 2B and 2C ). We thus concluded that ADAM12 is necessary for local invasion and distant metastasis downstream of Twist1.
ADAM12 is required for invadopodia-mediated ECM degradation.
Next, we sought to understand the cellular function of ADAM12 in tumor invasion and metastasis. ADAM12 localizes at invadopodia and directly interacts with the invadopodia-specific scaffolding protein Tks5 (Abram et al., 2003) . Given the critical role of Twist1 in promoting invadopodia-mediated ECM degradation, we suspected that ADAM12 might be a key downstream mediator of Twist1 in promoting invadopodia formation. First, we verified that endogenous ADAM12 protein localized to invadopodia in Hs578T cells grown on collagen by staining for cortactin, F-actin, and ADAM12. Robust colocalization of ADAM12 with puncta of F-actin and cortactin corresponding to invadopodia was observed ( Fig. 3A and 3B ). When ADAM12 was knocked down in both Hs578T and HMLE-Twist1 cells ( Fig. 3C and Fig. 1C ), we observed a significant decrease in F-actin/cortactin positive invadopodia formation. Interestingly, we observed that most of the cortactin was associated with cortical actin at the edge of the HMLE-Twist1 cells expressing shADAM12 constructs ( Fig. 3D-3G ). Together, these data demonstrate that ADAM12 is required for TWIST1-induced invadopodia formation.
Next we went on to test whether ADAM12 affects the ability of the cells to degrade ECM with the FITC-gelatin degradation assay. In these assays, areas of gelatin degradation or proteolysis are visualized as dark areas beneath the cell as the fluorescent FITC-labeled gelatin is degraded by the action of invadopodia. Indeed, a significant decrease in gelatin degradation was observed upon knockdown of ADAM12, indicating that ADAM12 is required for gelatin degradation ( Fig. 4A and 4B ). Furthermore, knocking down ADAM12 also significantly reduced the ability of these cells to invade through Matrigel-coated Boyden chambers (Fig. 4C) . Together, these data demonstrate that ADAM12 functions downstream of Twist1 in promoting invadopodia-mediated matrix degradation and tumor invasion.
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In the course of characterizing the role of ADAM12 in regulating cell invasion, we tested whether ADAM12 regulates cell migration. Surprisingly, in both HMLE-Twist1 and
Hs578T cells, knockdown of ADAM12 drastically decreased cell migration in Transwell migration assays ( Fig. 5A and 5B). To further assay defects in cell motility, we also performed scratch assays with the same cell lines used above. A significant decrease in motility upon knockdown of ADAM12 was observed over all time points examined ( Fig.   S3A and S3B). Together, these results show that in addition to promoting invasion, ADAM12 also regulates cell motility. To understand the underlying mechanism, we first noticed that upon knocking down ADAM12, these cells appeared more spread out and were significantly larger than the control cells (Fig. 5C ). When quantified by measuring the relative surface area of each cell, a significant difference in apparent cell size was noted ( Fig.   5D ). Increased cell size in two dimensions can be due to either an intrinsic increase in cell volume or an increase in cell spreading (Xiong et al., 2010) . We therefore measured the volume of HMLE-Twist1 and Hs578T cells expressing shCtrl and shADAM12 constructs in suspension. There was no significant difference in cell volume upon knockdown of ADAM12
( Fig. S3C and S3D ), implying that the apparent increase in cell size is due to an increase in cell spreading rather than an actual increase in cell volume.
Increased cell spreading directly correlates with increased focal adhesion number (Tamura et al., 1998) . This was particularly interesting in light of the fact that ADAM12 is shown to interact with integrins involved in focal adhesions (Kveiborg et al., 2008) . Indeed, when Hs578T cells were stained for ADAM12 and the focal adhesion protein vinculin, ADAM12 localized to focal adhesions on the periphery of the cell ( Fig. 5E and 5F ). This is consistent with previous reports that ADAM12 localizes to both invadopodia and peripheral areas of the cell (Abram et al., 2003; Kawaguchi et al., 2003) . We therefore assayed focal adhesion formation by staining both Hs578T and HMLE-Twist1 cells expressing control and shADAM12 vectors for vinculin. A clear increase in focal adhesion formation (elongated ellipsoid vinculin staining adjacent to F-actin stress fibers) was observed upon ADAM12 knockdown ( Fig. 6A and 6B ). Stress fiber formation requires focal adhesion formation and is a surrogate marker for focal adhesion formation in many cell lines. Indeed, F-actin staining showed that stress fiber formation also significantly increased upon knockdown of ADAM12
( Fig. 6A and 6C ).
Increased attachment strength is associated with focal adhesions and increased interactions with the surrounding matrix (Elineni and Gallant, 2011) . To determine whether the increase in focal adhesion number upon ADAM12 knockdown affected the adhesive properties of the cells, we performed a cell detachment assay. Briefly, sub-confluent Hs578T cells expressing shCtrl or shADAM12 constructs were treated with 0.05% trypsin for the indicated amount of time before washing, fixing, and staining with crystal violet to quantify the percentage of cells remaining attached. Significantly, cells expressing shADAM12 were more resistant to trypsin-mediated detachment ( Fig. 6D ), indicating that ADAM12 expression reduces cell-ECM attachment.
Focal adhesion kinase (FAK) is a downstream effector of focal adhesion activation (Schlaepfer et al., 1999) . Autophosphorylation of FAK at tyrosine 397 is an early event in
focal adhesion formation and is required for subsequent signaling through Src kinase and PI3-K (Schlaepfer and Hunter, 1997) . We therefore investigated the status of FAK phosphorylation upon knockdown of ADAM12 in Hs578T cells. Knocking down ADAM12
with both shRNAs induced a greater than four-fold increase in Y397FAK phosphorylation ( Fig. 6E ), supporting a role of ADAM12 in reducing cell-matrix interaction in tumor cells.
Lastly, we analyzed the turnover of adhesions in Hs578T ADAM12 knockdown cells.
Cells transfected with paxillin-mCherry were imaged using live-cell confocal microscopy for one hour time-lapse acquisitions ( Fig. 6F and Movie 1). We found that ADAM12 knockdown cells formed focal adhesions that were significantly more stable than those formed in control cells (Fig. 6F and 6G) . Additionally, ADAM12 knockdown cells also formed significantly less dynamic adhesions when compared to control cells (Fig. 6G ). This effect on focal adhesion lifetime is also evident in the dynamic adhesion heat maps (Fig S4) , where the color of the focal adhesion is a function of its lifetime and stability (SantiagoMedina et al., 2012) . Taken together, these findings support a role for ADAM12 in maintaining adhesion turnover as well as a population of dynamic focal adhesions.
The disintegrin and MMP domains of ADAM12 have distinct roles in regulating invadopodia vs. focal adhesions.
ADAM12 has multiple functional domains, including a metalloprotease domain that cleaves other proteins, a disintegrin domain that interacts with integrins, and a cytoplasmic
Journal of Cell Science • Advance article tail that may act as a scaffold for signaling or a physical linkage to the cytoskeleton (Kveiborg et al., 2008) . To determine what domains of ADAM12 were necessary for its roles in focal adhesion and invadopodia regulation, we performed a series of rescue experiments with two mutant ADAM12 proteins, including a metalloprotease-null ADAM12 (E351Q, A12ΔMMP) and a disintegrin domain mutant ADAM12 (D488A, A12ΔDis) (Fig. 7A ). The metalloprotease mutation disrupts a critical catalytic glutamate, while the disintegrin mutation replaces a critical charged aspartate with an uncharged alanine residue (Huang et al., 2005; Jacobsen et al., 2008) .
Hs578T-shADAM12 cells transiently transfected with ADAM12 constructs on 0.1% collagen were stained for vinculin and F-actin to visualize focal adhesions. These cells were transfected along with Lifeact-mCherry to identify the transfected cells. The metalloprotease-null ADAM12 mutant constructs reduced focal adhesion number similar to the wild-type ADAM12, while the disintegrin domain mutant ADAM12 failed to do so ( Fig.   7B ), suggesting a key role of the disintegrin domain in regulating cell-matrix adhesion.
Consistently, the metalloprotease-null ADAM12 mutant could also rescue the focal adhesion defects due to knockdown of ADAM12 in HMLE-Twist1 cells (Fig. S5) . Next, invadopodia formation was assayed by quantifying cells positive for punctate co-localization of F-actin and cortactin. Only the full-length ADAM12 was able to increase invadopodia formation to levels comparable to Hs578T-shCtrl cells, while both A12ΔMMP and A12ΔDis mutants failed to significantly rescue the invadopodia defects (Fig. 7C) . Interestingly, co-transfection of both A12ΔMMP and A12ΔDis could significantly rescue invadopodia formation, suggesting that both mutant forms of ADAM12 can function in trans to support invadopodia formation. To assess whether restoration of invadopodia formation resulted in functional ECM degradation, Hs578T-shADAM12 cells transfected with various ADAM12 mutant constructs were assayed for their matrix degradation abilities. Indeed, A12ΔMMP and A12ΔDis together could significantly rescue matrix degradation (Fig. 7D ). Taken together, these results indicate that ADAM12 utilizes multiple domains to mediate its role in ECM adhesion and degradation: the disintegrin domain of ADAM12 is required for focal adhesion turnover, while both the MMP domain and the disintegrin domains regulate invadopodia formation and function.
DISCUSSION
In this study, we identify ADAM12 as a novel downstream effector of Twist1 in promoting tumor cell migration, invasion, and metastasis. We show that ADAM12 is required for invadopodia formation and matrix degradation to promote tumor invasion; furthermore, ADAM12 weakens focal adhesions to promote cell migration. Together, both functions of ADAM12 contribute to its critical role in mediating Twist1-induced tumor metastasis in vivo.
Although strongly upregulated in response to Twist1 activation, it is unlikely that ADAM12 is a direct transcriptional target of Twist1. The ADAM12 promoter lacks Twist1-responsive E-box elements and it is induced relatively slowly in response to Twist1 to be a direct target. Interestingly, transfection of cells with Akt1 or inhibition of mammalian target of rapamycin (mTOR) led to increased transcription of ADAM12 in head and neck cancer cell lines (Le Pabic et al., 2005) . Twist1 has been reported to increase Akt2 activation in breast cancer cell lines, suggesting a possible link between ADAM12 and Twist1 through regulation of Akt activity (Cheng et al., 2007) . Furthermore, Hypoxia-induced Notch activation has been shown to induce ADAM12 expression (Diaz et al., 2013) . Since HIF1α is also shown to directly induce Twist1 , suggesting that hypoxia in the tumor microenvironment could induce ADAM12 via two distinct mechanisms, Notch activation and Twist1.
A potential role for ADAM12 in invadopodia has been suspected since the discovery that ADAM12 directly interacts with the invadopodia-specific scaffolding protein Tks5 (Abram et al., 2003) . Characterization of the function of ADAM12 at invadopodia has been limited to the observation that inducing clustering of ADAM12 with a monoclonal antibody induces localized EGF-shedding and invadopodia formation . In rescue experiments, we observed that both the disintegrin domain and metalloprotease domain of ADAM12 were necessary for rescuing the invadopodia formation defect and they could function in trans to do so. Adhesion rings containing integrins are found at invadopodia and shown to be critical for invadopodia maturation (Branch et al., 2012) . Therefore, the disintegrin domain of ADAM12 could potentially regulate adhesion ring dynamics around invadopodia to impact invadopodia formation.
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Several previous reports have also suggested that focal adhesions inhibit invadopodia formation. It has been hypothesized that focal adhesions sequester Src to areas at the periphery of the cell, reducing the pool of Src kinase available to phosphorylate invadopodia components (Chan et al., 2009) . A similar phenotype was observed in melanoma, in which suppression of focal adhesions led to decreased migration, but increased invadopodia (KolliBouhafs et al., 2014) . We show that ADAM12 knockdown significantly inhibited focal adhesion turnover. Disruption of the kinetics of focal adhesion turnover and maturation leads to decreased invasion in other model systems (Fukumoto et al., 2015) . Therefore, it is also likely that ADAM12 regulates focal adhesion turnover to impact invadopodia formation and activity.
It is worth noting that ADAM12 has two mRNA splicing isoforms, ADAM12-L (transmembrane) and ADAM12-S (secreted). Several studies have reported important roles of ADAM12-S in promote invasion in breast tumor cells (Roy and Moses, 2012) and during trophoblast fusion (Aghababaei et al., 2014) , in which the proteolytic activity of ADAM12-S is required. Although it is possible that ADAM12-S could also regulate invadopodia function to impact invasion, the ability of ADAM12-L to rescue invadopodia and focal adhesion defects due to ADAM12 gene knockdown observed in our study suggest that ADAM12-L plays a cell-autonomous role in regulating invadopodia and focal adhesion dynamics, independent of ADAM12-S.
Previous reports have implied a link between ADAM12 and tumor growth in vivo. In both mouse mammary cancer and prostate cancer models, transgenic expression of ADAM12 induces increased proliferation or reduced apoptosis in the primary tumor (Kveiborg et al., 2005; Peduto et al., 2006) . Deletion of ADAM12 in MMTV-PyMT tumors reduced tumor cell proliferation due to defective Akt activation (Frohlich et al., 2011) . Similarly, knocking down Tks5, another critical invadopodia protein, in the same HMLER-Twist1 cells did not affect growth rate in vitro or in vivo, while knockdown of Tks5 in MDA-MB-231 cells resulted in reduced cell growth in 3D culture and in mice without changing cell proliferation rate on 2D plastic dishes (Blouw et al., 2015) . In contrast, we observed no overt growth defects in vitro or in vivo. This is likely due to difference in cooperative genetic and epigenetics changes in individual systems and our use of constitutively active H-Ras in our xenotransplantation model of metastasis, which override the requirement for Akt activation.
It is important to note that in all these cases, invadopodia are essential for the invasive behavior of tumor cells, regardless of their requirements in tumor growth or not.
Combining these data, we propose a model in which ADAM12 increases focal adhesion dynamics and turnover. These dynamics increase both the migratory ability of cells and invadopodia formation. This combined increase in migration and invadopodia formation promotes Twist1-induced local invasion and eventual tumor metastasis.
Materials and methods
Cell Lines: HMLE cells were generated in Robert Weinberg's lab. Hs578T cells were from Dr. Sara Courtneidge. HMLE cells were cultured as previously described (Yang et al., 2004) . Hs578T breast carcinoma cells were maintained in Dulbecco's modification of Eagle's Media supplemented with 10% fetal bovine serum and insulin (Sigma-Aldrich). Cell authentication was performed per ATCC guidelines using morphology, growth curves, and
Mycoplasma testing (MycoAlert, Lonza) within 6 months of use.
Antibodies: Antibodies were used at the following concentrations: ADAM12 (GeneTex, added to the recipient cell lines with 6 μg/ml protamine sulfate for a 4 hr infection. HMLE and Hs578T cells were then selected with 2 μg/ml puromycin (EMD Biosciences), or 10 μg/ml blasticidin (Invitrogen).
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Plasmids: The three shRNA lentiviral constructs against Twist1 in the pSP108 vector were described previously (Yang et al., 2004) . ADAM12 was subcloned into pWb expression construct from pcDNA3.1 by ligation into pWZL-Blast mammalian expression vector after cutting with XhoI/SalI restriction enzymes. The shRNA constructs against ADAM12 were created using the Invitrogen Blockit RNAi Designer. Candidate shRNAs were screened with NCBI BLAST to ensure specificity. Oligos were synthesized by Integrated DNA Technologies and were cloned into pSp81 vector with BstBI and BamHI restriction digestion followed by ligation. The shRNA constructs with associated U6 lentiviral promoter cassette and construct were cloned into pSp108 transfer vector with BamHI and SalI cuts followed by ligation.
Site-Directed Mutagenesis:
Primers were generated for mutagenesis using PrimerX software to target the described residues in ADAM12. Primers were synthesized by Integrated The final gel degradation index is the average percentage degradation per cell obtained from all ten fields. Each experiment was repeated at least three times.
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Immunofluorescence: Matrix substrates were prepared by coating glass coverslips with 0.1% rat tail collagen I in DMEM for one hour. 20,000 cells were seeded onto coverslips in a 24 well plate and collected following three days of incubation. Cells were fixed at 37°C in 4% paraformaldehyde (PFA)/PBS with 50 μM CaCl 2 for 15 min, permeabilized with 0.1% Triton X-100/PBS for 10 min, and blocked with 5% goat serum. Samples were incubated with primary antibodies overnight at 4°C and with secondary antibodies and/or phalloidin (Invitrogen) for 2 hr.
After washing, coverslips were mounted with VectaShield HardSet (Vector Laboratories).
Images were collected with an Olympus FV1000 confocal microscope.
Quantification of Cell Size:
Images of cells on 0.1% collagen coated 24 well plates or in suspension were collected and identical thresholds applied to all images to isolate area of cell.
Total area of cells was calculated using ImageJ. Relative areas were calculated by normalization to cells expressing shCtrl constructs.
Trypsin Release Assay: 24 well plates were coated with 0.1% rat tail collagen I diluted in DMEM for one hour. Cells were plated on 0.1% rat tail collagen I matrix in a 24 well plate and allowed to sit for 48 hours. 0.05% trypsin was added into each well for the indicated amounts of time. Trypsin was inactivated by addition of an equal volume of 10% calf serum in DMEM. Wells were rinsed with PBS, fixed with 4% PFA, and stained with 0.1% crystal violet.
Acetic acid was used to extract crystal violet from cells and the amount of crystal violet extracted was quantified as absorbency at 590 nm. Relative cell number, normalized to un-trypsinized samples, was quantified for each time point. integrin blocking antibody (decrease in focal adhesions) to ensure that changes in focal adhesion number were captured with the algorithm.
Quantification of Focal Adhesion and Stress
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Live-cell imaging time-lapse microscopy: Cells cultured for 16 hours on 0.1% rat tail collagen were transfected with paxillin-mCherry (kind gift from David Schlaepfer) and imaged 48 hours after transfection using a confocal microscope suited with an environmental control chamber.
Dynamic Adhesion Maps: Dynamic adhesion map images were prepared from image stacks as detailed previously (Santiago-Medina et al., 2012) . Briefly, an image stabilization algorithm was applied, and an unsharp mask routine was applied, to improve edge detection, followed by thresholding to highlight paxillin adhesions. An 8-bit binary filter was applied to equalize adhesion intensities. Image stacks were then converted to 16-bit and user-defined subsets were summed so that intensity encodes pixel lifetime. Final images were pseudocolorized using the lookup table of ImageJ. 
Three-Dimensional Cell
Quantification of Invasive Spheroids:
After one week in 3D culture (described above), images were collected of spheroid structures. Structures were counted as invasive if they had projections from the main spheroid body that extended farther than half the diameter of the spheroid. Structures that did not have a well-defined spheroid structure were not quantified.
Images were analyzed with ImageJ software. Crystal violet was released with 50 μL 10% acetic acid and absorbency was measured at 590 nm.
Subcutaneous Tumor Implantation and Metastasis
Identical protocols were used for migration assays using Transwells without Matrigel. All assays were performed in triplicates.
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